A Stephen Sherwin
Affiliations
- Director at Neurocrine Biosciences Inc (NBIX), 2023-11-20
- Director at Biogen Inc. (BIIB), 2023-06-28
- Director at Epiphany Technology Acquisition Corp. (EPHY), 2022-10-04
- Director at Bioplus Acquisition Corp. (BIOS), 2021-12-03
- Director at Aduro Biotech Inc. (ADRO), 2020-05-28
- Director at Neon Therapeutics Inc. (NTGN), 2020-05-07
- Director at Rigel Pharmaceuticals Inc (RIGL), 2016-05-12
- Director at Verastem Inc. (VSTM), 2015-06-16
- Director at Vical Inc (VICL), 2015-05-26
- Director at Biosante Pharmaceuticals Inc (BPAX), 2012-03-30
- Officer, Director at Cell Genesys Inc (CEGE), 2009-10-15
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
VSTM | $8.56 | 2,500 | Director | 2,500 | 2014-12-26 | Filing | |
VICL | $0.01 | 7,003 | Director | 7,003 | 2013-05-23 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
NBIX | $118.85 | 15,000 | Director | 25,055 | 2023-01-03 | Filing | |
NBIX | $118.87 | 15,000 | Director | 25,055 | 2023-01-03 | Filing | |
NBIX | $74.43 | 15,000 | Director | 25,055 | 2022-01-24 | Filing | |
NBIX | $99.39 | 17,687 | Director | 29,861 | 2020-04-28 | Filing | |
BIIB | $295.29 | 270 | Director | 15,438 | 2020-03-11 | Filing |